Effect of kasni seeds (A unani drug) on obesity related disorders.

Therapeutic potential of Cichorium intybus seed supplementation on life style disorders

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/12/006435

Enrollment

150

Registered

2015-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: C. intybus aqueous extract capsule: 500 mg: Chicory seed capsules obtained from M/S Hamdard laboratories (pvt.), shall be administered twice a day, 30 minutes before a meal for 12 we

Eligibility

Inclusion criteria

Inclusion criteria: a)Metabolic syndrome, otherwise healthy subject (BMI >25) b)Patient groups-T2 DM cases, metabolic syndrome with CAD

Exclusion criteria

Exclusion criteria: 1.Type 1 diabetes cases 2.All critically ill patients, renal failure. 3.Cirrhosis liver, jaundice, cancers 4.Patients on estrogen, corticosteroid, valproate) 5.Alcohol addicts.

Design outcomes

Primary

Measure	Time frame
Therapeutic application of feeding C.intybus seed in aqueous extract form on i) Glucose profile ii) Lipid profile iii) cardiac markers iv) inflammatory marker and v) Antioxidant statusTimepoint: 1st year- Case registration in pilot study and Base line study 2nd year- Midterm evaluation, Full term evaluation, Standardization techniques , Cell culture study, Biochemical assays 3 rd year- Cell culture study continued, Data analysis	—

Measure

Time frame

Therapeutic application of feeding C.intybus seed in aqueous extract form on i) Glucose profile ii) Lipid profile iii) cardiac markers iv) inflammatory marker and v) Antioxidant statusTimepoint: 1st year- Case registration in pilot study and Base line study 2nd year- Midterm evaluation, Full term evaluation, Standardization techniques , Cell culture study, Biochemical assays 3 rd year- Cell culture study continued, Data analysis

—

Secondary

Measure	Time frame
To elucidate the mechanism of action of C.intybus aqueous extract for its role in antinflammatory, anti- diabetic, antioxidant.Timepoint: 1st year- Case registration in pilot study and Base line study 2nd year- Midterm evaluation, Full term evaluation, Standardization techniques , Cell culture study, Biochemical assays 3 rd year- Cell culture study continued, Data analysis	—

Countries

India

Contacts

Public ContactKailash Chandra

Faculty of Unani, Jamia Hamdard

ajabin@jamiahamdard.ac.in9899315252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026